|
About the Events / Workshops / Webinars category
|
|
0
|
738
|
April 14, 2021
|
|
FDA-CDER and HESI | Nitrosamine Ames Data Review and Method Development Workshop
|
|
2
|
372
|
May 6, 2026
|
|
Generic Drugs Forum (GDF) 2026
|
|
17
|
673
|
May 5, 2026
|
|
Benchmark Dose (BMD) Modeling for Risk Assessment webinar
|
|
1
|
231
|
May 4, 2026
|
|
🇺🇸 FDA Workshop - Nitrosamine-driven Reformulation and Bioequivelance
|
|
1
|
226
|
April 17, 2026
|
|
FDA/CRCG Workshop on Bioequivalence Innovations for Generic Oral Products
|
|
0
|
98
|
April 11, 2026
|
|
Science-led approaches to nitrosamine qualification and safety assessment-webinar
|
|
0
|
117
|
April 11, 2026
|
|
N-Nitrosamine Risk Management: From Toxicology to Targeted Analysis-Webinar
|
|
1
|
301
|
April 7, 2026
|
|
Everthing you wanted to know about In vivo COMET assay -webinar
|
|
0
|
89
|
April 3, 2026
|
|
All are welcomed to participate in the Stakeholder Survey concerning a Potential USP Public Standard on Mutagenic Impurities
|
|
0
|
112
|
April 2, 2026
|
|
Register for Free Webinar- Australia and New Zealand: Nitrosamines Impurities 19 March 2026
|
|
0
|
217
|
March 10, 2026
|
|
Register for Quality Hour- Japan Edition: Nitrosamines Impurities 18 March 2026
|
|
0
|
221
|
March 8, 2026
|
|
N-nitroso-Duloxetine recall back in the news!
|
|
21
|
4764
|
March 7, 2026
|
|
The Bench Mark dose (BMD) - Recorded full two day training FREE
|
|
4
|
384
|
March 4, 2026
|
|
Podcast: Reducing Nitrosamines and Driving Patient Safety
|
|
0
|
140
|
February 23, 2026
|
|
Nitrites/Nitrosamines: The impacts on analytics, but not only
|
|
0
|
182
|
February 17, 2026
|
|
10th Impurities: Genotoxic, Nitrosamine, & Beyond Summit
|
|
2
|
382
|
February 2, 2026
|
|
Live Q&A hosted by Andy Teasdale
|
|
0
|
175
|
January 30, 2026
|
|
🇹🇷 USP is hosting a user event (and I will be there! 👨🔬)
|
|
4
|
298
|
January 20, 2026
|
|
🇪🇬 EDA Workshop: Nitrosamine Impurities, Risk Assessment, Control Strategies, and Regulatory Compliance
|
|
3
|
350
|
January 14, 2026
|
|
🇺🇸 FDA Information Session on Generic Drug Research Needs & Opportunities for FY 2026
|
|
0
|
253
|
January 12, 2026
|
|
Happy 2026 Nitroso-warrior!
|
|
5
|
468
|
January 9, 2026
|
|
Calling our Risk Assessment Experts
|
|
52
|
1713
|
December 30, 2025
|
|
Nitrosamine Bootcamp in Indonesia & Korea
|
|
0
|
239
|
November 4, 2025
|
|
Advancing Generic Drug Development: Translating Science to Approval 2025
|
|
3
|
449
|
October 10, 2025
|
|
Risk Assessment Tool community review -launch
|
|
6
|
936
|
April 8, 2026
|
|
Nitrosamines and NOx at AAPS in San Antonio November 25
|
|
1
|
250
|
August 20, 2025
|
|
🇺🇸 FDA - Fiscal Year 2024 Generic Drug Science and Research Initatives Public Workshop
|
|
21
|
2153
|
August 7, 2025
|
|
🇦🇷 Nitrosaminas en Fármacos. Academia Nacional de Farmacia y Bioquimica
|
|
0
|
207
|
July 1, 2025
|
|
Optimizing Pharmaceutical Formulations: Strategies for Improving Stability and Minimizing Nitrosamine Impurities-Webinar
|
|
1
|
353
|
June 20, 2025
|